Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression

BACKGROUND: Tumor necrosis factor alpha (TNF-α) blockers are recognized as a risk factor for reactivation of granulomatous infections. Leishmaniasis has been associated with the use of these drugs, although few cases have been reported. METHODOLOGY: We performed a retrospective observational study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosch-Nicolau, Pau, Ubals, Maria, Salvador, Fernando, Sánchez-Montalvá, Adrián, Aparicio, Gloria, Erra, Alba, Martinez de Salazar, Pablo, Sulleiro, Elena, Molina, Israel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742442/
https://www.ncbi.nlm.nih.gov/pubmed/31469834
http://dx.doi.org/10.1371/journal.pntd.0007708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742442/
https://www.ncbi.nlm.nih.gov/pubmed/31469834
http://dx.doi.org/10.1371/journal.pntd.0007708

Ejemplares similares